SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-038915
Filing Date
2019-08-09
Accepted
2019-08-09 16:30:44
Documents
13
Period of Report
2019-08-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv527232_8k.htm   iXBRL 8-K 44463
2 EXHIBIT 3.1 tv527232_ex3-1.htm EX-3.1 6922
  Complete submission text file 0001144204-19-038915.txt   229688

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA asmb-20190806.xsd EX-101.SCH 3193
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE asmb-20190806_lab.xml EX-101.LAB 33476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asmb-20190806_pre.xml EX-101.PRE 21963
6 EXTRACTED XBRL INSTANCE DOCUMENT tv527232_8k_htm.xml XML 3585
Mailing Address 11711 N. MERIDIAN STREET SUITE 310 CARMEL IN 46032
Business Address 11711 N. MERIDIAN STREET SUITE 310 CARMEL IN 46032 (212) 554-4388
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35005 | Film No.: 191013330
SIC: 2834 Pharmaceutical Preparations